Cargando…
Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease
Alcoholic liver disease (ALD) is a complicated disease which can lead to hepatocellular carcinoma; however, there is a lack of satisfactory therapeutics. Dehydroeburicoic acid (DEA) (1), a triterpenoid isolated from Antrodia cinnamomea, has been reported to act against ALD, but its mechanisms of act...
Autores principales: | Cheng, Shasha, Kuang, Yi, Li, Guodong, Wu, Jia, Ko, Chung-Nga, Wang, Wanhe, Ma, Dik-Lung, Ye, Min, Leung, Chung-Hang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866905/ https://www.ncbi.nlm.nih.gov/pubmed/36678511 http://dx.doi.org/10.3390/ph16010014 |
Ejemplares similares
-
Interference reduction isothermal nucleic acid amplification strategy for COVID-19 variant detection
por: Li, Guodong, et al.
Publicado: (2023) -
A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1–Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury
por: Li, Guodong, et al.
Publicado: (2021) -
Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells
por: Cheng, Shasha, et al.
Publicado: (2021) -
A long-lived peptide-conjugated iridium(iii) complex as a luminescent probe and inhibitor of the cell migration mediator, formyl peptide receptor 2
por: Vellaisamy, Kasipandi, et al.
Publicado: (2018) -
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
por: Cheng, Sha-Sha, et al.
Publicado: (2020)